Preoperative smoking status and long-term survival after coronary artery bypass grafting: a competing risk analysis

Data de publicação:

Autores da FMUP

  • Joaquim Adelino Correia Ferreira Leite Moreira

    Autor

Participantes de fora da FMUP

  • Abreu A.
  • Máximo J.D.

Unidades de investigação

Abstract

OBJECTIVES: Patients with severe coronary artery disease who undergo coronary artery bypass grafting consistently demonstrate that continued smoking after surgery increases late mortality rates. Smoking may exert its harmful effects through the ongoing chronic process of atherosclerotic progression both in the grafts and the native system. However, it is not clear whether cardiac mortality is primary and solely responsible for the inferior late survival of current smokers. METHODS: In this retrospective analysis, we included all consecutive patients undergoing primary isolated coronary artery bypass surgery from 1 January 2000 to 30 September 2015 in an Academic Hospital in Northern Portugal. The predictive or independent variable was the patients' smoking history status, a categorical variable with 3 levels: non-smoker (the comparator), ex-smoker for >1 year (exposure 1) and current smoker (exposure 2). The primary end point was long-term all-cause mortality. Secondary outcomes were long-term cause-specific mortality (cardiovascular and noncardiovascular). We fitted overall and Fine and Gray subdistribution hazard models. RESULTS: We identified 5242 eligible patients. Follow-up was 99.7% complete (with 17 patients lost to follow-up). The median follow-up time was 12.79years (interquartile range, 9.51-16.60). Throughout the study, there were 2049 deaths (39.1%): 877 from cardiovascular causes (16.7%), 727 from noncardiovascular causes (13.9%) and 445 from unknown causes (8.5%). Ex-smokers had an identical long-term survival than non-smokers [hazard ratio (HR) 0.99; 95% confidence interval (CI) 0.88, 1.12; P¼0.899]. Conversely, current smokers had a 24% increase in late mortality risk (HR 1.24; 95% CI 1.07, 1.44; P¼0.004) as compared to non-smokers. While the current smoker status increased the relative incidence of noncardiac death by 61% (HR 1.61; 95% CI 1.27, 2.05, P<0.001), it did confer a 25% reduction in the relative incidence of cardiac death (HR 0.75; 95% CI 0.59, 0.97; P¼0.025). CONCLUSIONS: Whereas ex-smokers have an identical long-term survival to non-smokers, current smokers exhibit an increase in late all-cause mortality risk at the expense of an increased relative incidence of noncardiac death. By subtracting the inciting risk factor, smoking cessation reduces the relative incidence of cardiac death. © The Author(s) 2024.

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Dados da publicação

ISSN/ISSNe:
1873-734X, 1010-7940

European Journal of Cardio-thoracic Surgery  Elsevier

Tipo:
Article
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Scopus: 1

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Portugal; Preoperative Period; Retrospective Studies; Risk Assessment; Risk Factors; Smoking; acute heart infarction; adult; aged; all cause mortality; analysis of variance; anemia; aortic atherosclerosis; Article; body mass; cardiopulmonary bypass; cardiovascular disease; cardiovascular mortality; cerebrovascular accident; Charlson Comorbidity Index; chronic kidney failure; chronic obstructive lung disease; Cochran Armitage trend test; competing risk analysis; controlled study; coronary artery bypass graft; coronary artery disease; creatinine clearance; diabetes mellitus; female; Fine and Gray subdistribution hazard model; follow up; hazard ratio; health care planning; homoscedasticity; hospitalization; human; hyperlipidemia; hypertension; ICD-10; ICD-9-CM; incidence; independent variable; Kaplan Meier method; long term survival; longitudinal study; major clinical study; male; middle aged; mort

Financiamento

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

The Canadian CABG or PCI in Patients with Ischemic Cardiomyopathy Trial (STICH 3C) - NCT05427370

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Ensaio Clínico Académico (STICH 3C) . Cornell University . 2023

Estudo do tratamento da doença valvular aórtica.

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Observacional Académico (AORTA) . UniC . 2019

Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Ensaio Clínico Académico (Ensaio AGTP II) . 2019

Aortic valve surgery with stented versus stentless bioprosthesis in patients with active infective endocarditis

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Endocarditis) . 2023

Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Bypass) . 2020

Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Aortic Valve Replacemen) . 2020

Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2021

"Aortic valve surgery in patients with infective endocarditis: mid-term follow-up of patients treated with the St. Jude medical trifecta™ valve"

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2022

Long-term survival after coronary artery bypass grafting: the relevance of surgical procedures analysed by propensity score methods.

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Arrtery bypass) . 2022

Abdominal Aortic Aneurysm - The Portuguese Case: Specificities and Consequences

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2022

New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2021

Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2020

Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação